Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass.
about
Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional studyRecommendations for preventing fracture in long-term care.Adherence with medications used to treat osteoporosis: behavioral insights.Recommandations en vue de la prévention des fractures dans les établissements de soins de longue durée.
P2860
Quality of life and health status with zoledronic acid and generic alendronate--a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Quality of life and health sta ...... usal women with low bone mass.
@en
Quality of life and health sta ...... d Onset and Sustained Efficacy
@nl
type
label
Quality of life and health sta ...... usal women with low bone mass.
@en
Quality of life and health sta ...... d Onset and Sustained Efficacy
@nl
prefLabel
Quality of life and health sta ...... usal women with low bone mass.
@en
Quality of life and health sta ...... d Onset and Sustained Efficacy
@nl
P2093
P2860
P1476
Quality of life and health sta ...... usal women with low bone mass.
@en
P2093
D Gamerdinger
R Moericke
P2860
P2888
P304
P356
10.1007/S00198-011-1834-4
P407
P577
2011-11-16T00:00:00Z